✦ LIBER ✦

Targeting the PI3K/Akt/mTOR Pathway in Malignancy: Rationale and Clinical Outlook

✍ Scribed by Cho, Daniel C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale for Targeting the PI3K/Akt/mTO

✍ Bartalucci, Niccolò; Guglielmelli, Paola; Vannucchi, Alessandro M. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 361 KB

Targeting the PI3K/Akt/mTOR pathway: Eff

✍ Jaclyn LoPiccolo; Gideon M. Blumenthal; Wendy B. Bernstein; Phillip A. Dennis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 706 KB

Targeting the PI3K/Akt/mTOR pathway: Eff

✍ Jaclyn LoPiccolo; Gideon M. Blumenthal; Wendy B. Bernstein; Phillip A. Dennis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 706 KB

2 Agents Targeting the mTOR-PI3K-Akt Pat

✍ Tabernero, J.; Dienstmann, R.; Macarulla, T.; Saura, C.; Argiles, G.; Alsina, M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Targeting the PI3K/AKT/MTOR pathway in K

✍ A Bhatt, P Bhende, B Damania 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 64 KB

Targeting the PI3K–AKT–mTOR pathway: pro

✍ Timothy A Yap; Michelle D Garrett; Mike I Walton; Florence Raynaud; Johann S de 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 634 KB